The effect of heparin on lung function following cardiopulmonary bypass.
The effect of heparin on alveolar dead space following cardiopulmonary bypass.
Nil
30 participants
Nov 30, 2004
Interventional
Conditions
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A double blind randomised trial comparing intravenous heparin versus placebo (5% glucose). The infusion will be commenced 8 - 10 hours prior to commencement of surgery and ceased prior to the insertion of lines or sternotomy.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000133639